Risk of Colorectal Adenomas in Women with Prior Breast Cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background and Aims
Longer life expectancy in patients with prior breast cancer may increase their risk of developing other primary cancers, including colorectal cancer (CRC). Whether the risk of developing CRC in this patient population is higher in comparison to those with no prior cancer remains unclear. The purpose of this study was to compare the prevalence of colorectal adenomas and any CRC in breast cancer survivors with those who have no history of prior cancer and assess any difference with use of antiestrogen therapy.
We compared the prevalence of colorectal cancer and adenomas in breast cancer survivors with that of a group of matched controls. Eligible survivors were ≤85 years of age; had initially been diagnosed with stage 0, I, II, or III breast cancer; had completed all cancer treatments with the exception of adjuvant antiestrogen therapy; and had no evidence of recurrence on follow-up. We used the screening colonoscopy database at our institution to identify age-, sex-, and race-matched controls with no history of cancer.
We identified 302 study-eligible breast cancer survivors and 302 matched controls. No colorectal cancers were found in either group. Forty-one breast cancer survivors and 30 controls had tubular adenomas; four survivors and three controls had villous adenoma; and eight survivors and ten controls had advanced adenoma. Multivariate regression analysis revealed that adjuvant antiestrogen therapy was not significantly associated with an increased risk of advanced adenoma.
The prevalence of colorectal adenomas in breast cancer survivors and controls was similar. Breast cancer survivors, including those receiving adjuvant antiestrogen therapies may follow the colorectal screening guidelines used for average-risk population.
- American Cancer Society. Cancer facts and figures 2010. Atlanta: American Cancer Society; 2010.
- Altekruse SF, Kosary CL, Krapcho M, et al. eds. SEER cancer statistics review, 1975–2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
- EBCTCG. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687–1717.
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66. CrossRef
- Giordano SH, Buzdar AU, Smith TL, et al. Is breast cancer survival improving? Cancer. 2004;100:44–52. CrossRef
- Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353:1659–1672. CrossRef
- Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006;13:776–782. CrossRef
- Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935–82. Natl Cancer Inst Monogr. 1985;68:99–112.
- Schaapveld M, Visser O, Louwman MJ, et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol. 2008;26:1239–1246. CrossRef
- Evans HS, Lewis CM, Robinson D, et al. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer. 2001;84:435–440. CrossRef
- Matesich SM, Shapiro CL. Second cancers after breast cancer treatment. Semin Oncol. 2003;30:740–748. CrossRef
- Brown LM, Chen BE, Pfeiffer RM, et al. Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat. 2007;106:439–451. CrossRef
- Eisen GM, Sandler RS. Are women with breast cancer more likely to develop colorectal cancer? Critical review and meta-analysis. J Clin Gastroenterol. 1994;19:57–63. CrossRef
- Ochsenkuhn T, Bayerdorffer E, Meining A, et al. Increased prevalence of colorectal adenomas in women with breast cancer. Digestion. 2005;72:150–155. CrossRef
- Newcomb PA, Solomon C, White E. Tamoxifen and risk of large bowel cancer in women with breast cancer. Breast Cancer Res Treat. 1999;53:271–277. CrossRef
- Kmet LM, Cook LS, Weiss NS, et al. Risk factors for colorectal cancer following breast cancer. Breast Cancer Res Treat. 2003;79:143–147. CrossRef
- Schoen RE, Weissfeld JL, Kuller LH. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer? Am J Gastroenterol. 1994;89:835–842.
- Khalil S, Ceccarelli F. Colorectal cancer after breast cancer: magnitude of risk in clinical practice and in the literature. Tumori. 2009;95:28–31.
- Srinivasan R, Yang YX, Rubin SC, et al. Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer. Am J Gastroenterol. 2005;100:2759–2764. CrossRef
- Newschaffer CJ, Topham A, Herzberg T, et al. Risk of colorectal cancer after breast cancer. Lancet. 2001;357:837–840. CrossRef
- Yabroff KR, Klabunde CN, Yuan G, et al. Are physicians’ recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med. 2011;26:177–184. CrossRef
- Holden DJ, Jonas DE, Porterfield DS, et al. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152:668–676.
- Steinwachs D, Allen JD, Barlow WE, et al. National Institutes of Health state-of-the-science conference statement: enhancing use and quality of colorectal cancer screening. Ann Intern Med. 2010;152:663–667.
- Hamilton SR, Vogelstein B, Kudo S, Riboli E, et al. Tumours of the colon and rectum. In: Hamilton SR, Aaltonen LA, eds. World Health Organization classifications of tumors: pathology and genetics of tumors of the digestive system. Lyon, France: IARC; 2000:103–142.
- Brose MS, Rebbeck TR, Calzone KA, et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst. 2002;94:1365–1372. CrossRef
- Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. Breast cancer linkage consortium. Lancet. 1994;343:692–695. CrossRef
- Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336:1401–1408. CrossRef
- Peelen T, de Leeuw W, van Lent K, et al. Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis. Int J Cancer. 2000;88:778–782. CrossRef
- Lin KM, Ternent CA, Adams DR, et al. Colorectal cancer in hereditary breast cancer kindreds. Dis Colon Rectum. 1999;42:1041–1045. CrossRef
- Johannsson O, Loman N, Moller T, et al. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers. Eur J Cancer. 1999;35:1248–1257. CrossRef
- Tang LY, Nugent Z, Demers AA, et al. Incidence of right-sided colorectal cancer after breast cancer: a population-based study. Am J Gastroenterol. 2009;104:1213–1220. CrossRef
- Yu GP, Schantz SP, Neugut AI, et al. Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States). Cancer Causes Control. 2006;17:411–420. CrossRef
- Levi F, Te VC, Randimbison L, et al. Cancer risk in women with previous breast cancer. Ann Oncol. 2003;14:71–73. CrossRef
- Cluze C, Delafosse P, Seigneurin A, et al. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study. Eur J Cancer Prev. 2009;18:343–348. CrossRef
- Wu CS, Tung SY, Chen PC, et al. Colorectal adenoma in patients with a history of breast cancer: a prospective study in Taiwan. Int J Clin Pract. 1997;51:493–494.
- Lieberman DA, Prindiville S, Weiss DG, et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003;290:2959–2967. CrossRef
- Amonkar MM, Hunt TL, Zhou Z, et al. Surveillance patterns and polyp recurrence following diagnosis and excision of colorectal polyps in a medicare population. Cancer Epidemiol Biomarkers Prev. 2005;14:417–421. CrossRef
- Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982;23:835–842. CrossRef
- Winawer SJ, Zauber AG, O’Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993;328:901–906. CrossRef
- Butterly LF, Chase MP, Pohl H, et al. Prevalence of clinically important histology in small adenomas. Clin Gastroenterol Hepatol. 2006;4:343–348. CrossRef
- Lieberman D, Moravec M, Holub J, et al. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology. 2008;135:1100–1105. CrossRef
- Bedenne L, Faivre J, Boutron MC, et al. Adenoma–carcinoma sequence or “de novo” carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer. 1992;69:883–888. CrossRef
- Peipins LA, Sandler RS. Epidemiology of colorectal adenomas. Epidemiol Rev. 1994;16:273–297.
- Neugut AI, Jacobson JS, De Vivo I. Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev. 1993;2:159–176.
- Risio M. The natural history of adenomas. Best Pract Res Clin Gastroenterol. 2010;24:271–280. CrossRef
- Shinya H, Wolff WI. Morphology, anatomic distribution and cancer potential of colonic polyps. Ann Surg. 1979;190:679–683. CrossRef
- Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658–662. CrossRef
- O’Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990;98:371–379.
- Cook LS, Weiss NS, Pharris-Ciurej N, et al. Colorectal cancer following tamoxifen therapy for breast cancer (United States). Cancer Causes Control. 2001;12:405–410. CrossRef
- Matsuyama Y, Tominaga T, Nomura Y, et al. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann Oncol. 2000;11:1537–1543. CrossRef
- Braithwaite RS, Chlebowski RT, Lau J, et al. Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med. 2003;18:937–947. CrossRef
- Rutqvist LE, Johansson H, Signomklao T, et al. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst. 1995;87:645–651. CrossRef
- Risk of Colorectal Adenomas in Women with Prior Breast Cancer
Digestive Diseases and Sciences
Volume 57, Issue 12 , pp 3240-3245
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Breast cancer survivors
- Colorectal cancer
- Industry Sectors
- Author Affiliations
- 1. Department of Medicine, University at Buffalo, 462 Grider Street, Buffalo, NY, 14215, USA
- 2. Division of Gastroenterology, Hepatology, and Nutrition, The University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 4.234, Houston, TX, 77030, USA